Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour GP can prescribe Wegovy in the UK, but in practice most people find the route more complicated than a straightforward appointment. Wegovy (semaglutide 2.4mg) is a prescription-only medicine, so a clinician must assess your suitability before any supply is lawful — but which clinician, and through which service, depends on how you're accessing treatment. Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. That eligibility is just the starting point; a prescriber then weighs your full medical history before approving anything.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This happens more often than people expect. You go in having read the headlines, you mention Wegovy, and your GP is sympathetic but cautious. They might tell you that they can't prescribe it yet, that there's a waiting list for the specialist service, or that your BMI doesn't quite reach the current NHS threshold. None of that means you've done anything wrong, it reflects where NHS access genuinely is right now.
Under the guidance from NICE's appraisal of semaglutide (TA875), Wegovy is recommended on the NHS only when it's delivered within a specialist weight management service offering multidisciplinary support. That's a meaningful clinical safeguard, but it also creates long waiting lists in many parts of England. Referral from a GP is the usual starting point, and it's one your GP can make, but what happens after that referral is not in their hands.
A separate change came into force from 1 April 2026: GP practices in England can now prescribe Wegovy directly under an updated QOF contract arrangement. Participation is voluntary, though, so whether your own practice has signed up varies. It's worth asking them directly. In Scotland, Wales and Northern Ireland, commissioning differs, so check with your local health board.
The short version: your GP is often the gatekeeper, but not always the prescriber, and waiting times for specialist services remain a real barrier for many people, which is why some patients explore getting Wegovy without needing to contact a GP at all.
When a GP or any other prescriber considers Wegovy, they're looking at more than a BMI number. Semaglutide is a Black Triangle medicine, meaning the MHRA keeps it under additional monitoring, and the clinical picture matters. A prescriber will typically consider your weight history, any weight-related conditions, medications you're already taking, and whether there are contraindications, a history of medullary thyroid carcinoma or pancreatitis, for instance, would give pause.
A question our prescribers hear most weeks is whether a GP can simply look at someone's BMI and write the prescription the same day. The honest answer is that the assessment needs to be thorough; BMI is a threshold, not the whole story. The NHS medicines information for semaglutide explains what the medicine does and what your prescriber needs to know, and it's worth reading before any appointment.
Wegovy is not suitable during pregnancy, while breastfeeding, or if you are actively trying to conceive. It is not licensed for under-18s. These are not optional considerations for a prescriber, they're part of the clinical decision every time.
If you're transferring from another provider or asking for a dose increase, expect your prescriber to ask for evidence of your current treatment. That applies whether you're seeing a GP or using a private online pharmacy.
Because NHS access is restricted and waiting lists are long, many people in the UK turn to a regulated private online pharmacy instead. This is a legitimate route, provided the pharmacy is registered with the GPhC, every prescription is written by a qualified Independent Prescriber, and the medicine comes through the licensed UK supply chain.
You can verify any UK online pharmacy on the GPhC public register; it takes about thirty seconds and is the single most useful check you can do. Pharmacies that supply Wegovy without a clinical consultation, or that seem to offer it as a simple purchase, are operating outside the law. The MHRA has issued repeated warnings about counterfeit and illegally sold weight-loss pens, fake pens have been found to contain entirely different substances.
At nume, consultations are reviewed the same day by a named GPhC-registered Independent Prescriber. There's no algorithm making clinical decisions. If you're exploring the cost side of things, the Wegovy pricing page sets out what a private prescription genuinely involves financially.
The private route doesn't require a GP referral. If you want to understand exactly how it works compared with going through your GP, the guide to getting Wegovy from a GP sets out the NHS path in more detail, and the guide for people who don't have access through their GP explains the alternative.
If your GP has told you that they're not yet set up to prescribe Wegovy, or that the NHS specialist waiting list is long, you have a few practical options. First, ask whether a referral has been or can be made, even a long wait starts with the referral. Second, check whether your practice has opted into the new GP prescribing contract. Third, consider whether a private regulated prescription route suits your circumstances.
If you've already been receiving treatment elsewhere and need to continue, see the page on accessing Wegovy without a referral for context on how transfer patients are handled. Questions about contacting a service directly can be directed to the nume support team (sorry, to the nume support team) who can tell you what a consultation involves before you commit.
Whichever route you take, the medicine is the same. The clinical standards, the licensed schedule, and the need for ongoing review don't change. If you're ready to see whether you're a good candidate for treatment, start your free consultation and a prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.